RxDoctor Payments DataLook up a doctor →

Andrew Kim, MD

Internal Medicine · Wauwatosa, WINPI 1184697625

Payments from drug & device makers

$2,324,790in general payments, 2019–2025

Across 394 payments — averaging $5900.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1.1M
  • Boehringer Ingelheim$948K
  • Merck$134K
  • Takeda Pharmaceuticals U.S.A., Inc.$31K
  • Janssen Research & Development, LLC$25K
  • Gilead$24K
  • plus $44K from 7 others

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,324,790 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.

See all internal medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$49,437
Medicare patients
98
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Wauwatosa

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →